Furthermore, plasma levels of HMGB1 correlated with plasma NET levels in stroke patients, and platelet-specific knockout of HMGB1 in mice prevented stroke-induced NET formation and improved stroke outcomes. Here, HMGB1 is linked to stroke disorder.